MYMin Yang

Min Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Min Yang has a total of 24 co-authors. Here are the top co-authors by number of shared publications:

  • Hongyan Niu

    Department of Nephrology, The Third Affiliated Hospital of Soochow University, Jiangsu Province, Changzhou, China

    4 shared publications
  • Hua Zhou

    Department of Nephrology, The Third Affiliated Hospital of Soochow University, Jiangsu Province, Changzhou, China

    4 shared publications
  • Wenhui Wu

    Department of Nephrology, The Third Affiliated Hospital of Soochow University, Jiangsu Province, Changzhou, China

    4 shared publications
  • Jia Di

    Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    3 shared publications
  • Xiurong Li

    Department of Nephrology, The Third Affiliated Hospital of Soochow University, Changzhou, China

    3 shared publications
  • Cai-Shan Wang

    Department of Ultrasound, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, 215004, China

    1 shared publication

Latest Publications

  • Open Access

    Effect of central dialysis fluid delivery system on markers of inflammation in hemodialysis patients

    by Yanhong Ni, Wenhui Wu, Hua Zhou, Min Li, Xiying Zhu, Hongyan Niu, Jinfeng Liu, Lina Xue, Yeqian Liu, Min Yang

    The utilization of ultrapure dialysate has been shown to decrease dialysate contamination and mitigate inflammatory responses. The central dialysate delivery system (CDDS) has the potential to attain a level of purity similar to ultrapure dialysate. Nevertheless, there is limited research examining the impact of CDDS on inflammation in comparison to single-patient dialysis fluid delivery system(SPDDS). This study aims to investigate the effects of CDDS utilizing ultrapure dialysate on ameliorating the microinflammatory state in hemodialysis patients. A retrospective cohort clinical study enrolled a total of 125 hemodialysis patients, with 58 patients from the CDDS unit and 67 patients from the SPDDS unit. Each participant was monitored for a period of 6 months, and the repeated measurement data was analyzed using a generalized linear mixed models (GLMM). The average age of the studty cohort was 56.22 ± 12.64 years. The GLMM analysis showed a significant time*group interaction effect on hs-CRP changes over the follow-up period (β = -1.966, FTime* CDDS group = 13.389, P < 0.001). A linear mixed model analysis with random slope showed that a different slope was observed between CDDS group and SPDDS group (βCDDS =—0.793; βSPDDS = 0.791), indicating a decreased hs-CRP levels in CDDS group, while increased in the SPDDS group over the follow-up period. However, no significant time*group interaction effect were observed on albumin and β2-microglobulin levels during follow-up period(β2-microglobulin: β = -0.658, FTime* CDDS group = 1.228, P = 0.269; albumin: β = 0.012, FTime* CDDS group = 1.429, P = 0.233). Using ultrapure dialysate in the CDDS is associated with an improvement in hs-CRP levels compared to standard dialysate, which might confer long-term clinical advantages.


  • Open Access

    Influencing factors of clinical efficacy of roxadustat among hemodialysis patients

    by Wenhui Wu, Nan Hu, Xiurong Li, Jia Di, Hua Zhou, Hongyan Niu, Min Yang

    To explore independent influencing factors for clinical efficacy of roxadustat in hemodialysis patients. Hemodialysis patients treated with roxadustat were enrolled. The plasma trough concentrations of roxadustat were measured using liquid chromatography-tandem mass spectrometry (LC-MS/MS). A multiple logistic regression model was established to determine the factors that affect clinical efficacy of roxadustat in patients undergoing hemodialysis. A total of 67 hemodialysis patients were enrolled in the study. The results showed that age, blood trough concentration of roxadustat, and baseline hemoglobin (Hb) level were independent factors of clinical efficacy of roxadustat (OR = 1.06, p = .025 for age; OR = 1.001, p = .037 for plasma concentration; and OR = 0.941, p = .003 for baseline Hb), with an AUC score of 0.859. Age, blood trough concentration of roxadustat, and baseline Hb level were independent influencing factors of the response to roxadustat in hemodialysis patients.


  • The relationship between dietary inflammatory index and bone mineral density in CKD patients

    by Wenhui Wu, Xiurong Li, Jia Di, Hua Zhou, Hongyan Niu, Lu Chen, Qi Sha, Min Yang

    Introduction: Chronic systemic inflammation was proposed as a critical factor in the development of osteoporosis. We aim to investigate the effect of the DII on bone mineral density (BMD) in CKD patients. Methods: 2276 participants from NHANES were enrolled. The DII score was calculated based on a single 24-h dietary recall. Total BMD was measured using Dual-energy x-ray absorptiometry. A multiple-stepwise linear regression model was used to determine associations between BMD and DII in CKD patients. Results: When DII >0.35, a negative correlation was obtained between DII and BMD (all ss = -0.008 and p < 0.05). In subgroup analysis, BMD levels decreased across increasing tertiles of the DII for patients with non-osteoporosis, postmenopause, and low eGFR (p for trend <= 0.01). Conclusion: Higher consumption of pro-inflammatory diet correlates negatively with the BMD levels in CKD patients.


  • Open Access

    Dietary inflammatory index is associated with Vitamin D in CKD patients

    by Wenhui Wu, Xiurong Li, Jia Di, Hua Zhou, Hongyan Niu, Min Yang

    Objectives: Multiple observational studies have shown that low serum level of 25-hydroxyvitamin D (25(OH)D) in patients with chronic kidney disease (CKD) have been associated with a faster progression of kidney disease and a higher risk of all-cause mortality. We aim to assess the association between dietary inflammatory index (DII) with Vitamin D in adults with CKD. Method: The National Health and Nutrition Examination Survey appropriated participants from 2009 to 2018 were enrolled. The patients who were under the age of 18, pregnant, and having incomplete data were excluded. DII score were calculated based on a single 24-h dietary recall interview for each participant. Mutivariable regression analysis and subgroup analysis were utilized to determine the independent associations between vitamin D with DII in CKD patients. Results: In total, 4283 individuals were finally included. The results showed a negative association between DII scores and 25(OH)D with statistical significance (β = – 1.83, 95% CI – 2.31, – 1.34, P < 0.001). In subgroup analysis stratified by gender, low eGFR, age and diabetes, the negative association between DII scores and 25(OH)D was still significant (all P for trend < 0.05). The results from interacion test indicated that the magnitude of the association was the same for the population with and without low eGFR (P for interacion = 0.464). Conclusion: Higher consumption of pro-inflammatory diet correlates negatively with the 25(OH)D level in CKD patients with and without low eGFR. Anti-inflammatory diet management may reduce the reduction of vitamin D in CKD patients.


  • Clinical study of transcranial sonography image characteristics in patients with obstructive sleep apnea

    by Qing-Yuan Liu, Min Yang, Yu-Jing Sheng, Xiao-Fang Chen, Cai-Shan Wang, Ying Zhang, Pan Mao, Chang-Wei Ding, Rui Chen, Ying-Chun Zhang, et al.

    Objective This study aimed to explore the relationship between patients with obstructive sleep apnea (OSA) from subgroups of varying severity and substantia nigra (SN) hyperechogenicity as well as cerebral blood flow detected by transcranial sonography (TCS). The study also explored if there were differences in damage of the SN and in the cerebral blood flow between the bilateral sides. Methods Right-handed men diagnosed with OSA by polysomnography were recruited from August 2018 to August 2020. The included patients were divided into 3 subgroups (mild, moderate, and severe OSA), and all patients underwent TCS. Results Among the 157 study patients (30 with mild OSA, 25 moderate, and 102 severe), the overall prevalence of SN hyperechogenicity was 15% (23/157). The hyperechogenicity detection rates were 3% (4/157) in the right SN subgroup and 13% (20/157) in the left SN subgroup, which were significantly different. The left side always had reduced blood flow on TCS (P < 0.05). No correlation was observed between the severity of OSA and the detection rates of SN hyperechogenicity (P > 0.05). Conclusion Patients with OSA showed a higher detection rate of SN hyperechogenicity on the left compared with the right side. The left middle cerebral arteries had reduced blood flow, which was consistent with the more severe damage of the left SN. No relationship was observed between the severity of OSA and the detection rate of SN hyperechogenicity or hemodynamic parameters.